MPTP and parkinson's disease
- 1 January 1985
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 8, 79-83
- https://doi.org/10.1016/0166-2236(85)90031-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigraNeuroscience Letters, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s DiseaseCanadian Journal of Neurological Sciences, 1984
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Site-Specific, Sustained Release of Drugs to the BrainScience, 1981
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979